Earnings calendar

Vertex Pharmaceuticals Incorporated (VRTX) earnings: date, estimates, results and stock reactions

Next earnings: Q1 FY2027 on 2027-02-11 (expected, time not announced). EPS estimate 4.20, revenue estimate 3.50B.

Over the last 12 reports the stock moved 4.6% on average (either way), rising 5 times and falling 7. EPS beat estimates 6 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q4 FY20262026-11-024.764.82-1.2%3.44B3.42B-5.0%
Q3 FY20262026-08-034.734.74-0.2%3.33B3.23B+0.3%
Q2 FY20262026-05-044.474.24+5.4%2.99B2.99B+0.1%
Q1 FY20262026-02-125.035.11-1.6%3.19B3.18B+6.6%
Q4 FY20252025-11-034.804.57+5.0%3.08B3.06B-0.9%
Q3 FY20252025-08-044.524.29+5.4%2.96B2.91B-18.9%
Q2 FY20252025-05-054.064.25-4.5%2.77B2.86B-10.2%
Q1 FY20252025-02-103.984.02-1.0%2.91B2.78B-3.0%

VRTX stock report · Earnings calendar